Open access · CC-BY
via OpenAlex
Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine
Vitale Miceli, Matteo Bulati, Gioacchin Iannolo, Giovanni Zito, Alessia Gallo, Pier Giulio Conaldi
International Journal of Molecular Sciences · 2021 · ▲ 176 citations
Abstract
Mesenchymal stromal/stem cells (MSCs) are multipotent adult stem cells that support homeostasis during tissue regeneration. In the last decade, cell therapies based on the use of MSCs have emerged as a promising strategy in the field of regenerative medicine. Although these cells possess robust therapeutic properties that can be applied in the treatment of different diseases, variables in preclinical and clinical trials lead to inconsistent outcomes. MSC therapeutic effects result from the secretion of bioactive molecules affected by either local microenvironment or MSC culture conditions. Hence, MSC paracrine action is currently being explored in several clinical settings either using a conditioned medium (CM) or MSC-derived exosomes (EXOs), where these products modulate tissue responses in different types of injuries. In this scenario, MSC paracrine mechanisms provide a promising framework for enhancing MSC therapeutic benefits, where the composition of secretome can be modulated by priming of the MSCs. In this review, we examine the literature on the priming of MSCs as a tool to enhance their therapeutic properties applicable to the main processes involved in tissue regeneration, including the reduction of fibrosis, the immunomodulation, the stimulation of angiogenesis, and the stimulation of resident progenitor cells, thereby providing new insights for the therapeutic use of MSCs-derived products.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms22020763
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Miceli, V., Bulati, M., Iannolo, G., Zito, G., Gallo, A., & Conaldi, P.G. (2021). Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms22020763
Vancouver
Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms22020763.
BibTeX
@article{vitale2021Therap,
title = {Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine},
author = {Vitale Miceli and Matteo Bulati and Gioacchin Iannolo and Giovanni Zito and Alessia Gallo and Pier Giulio Conaldi},
journal = {International Journal of Molecular Sciences},
year = {2021},
doi = {10.3390/ijms22020763},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Nanomedicine 2019
Open access · CC-BY
Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy
World Journal of Gastroenterology 2015
Open access · CC-BY
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
Signal Transduction and Targeted Therapy 2025
Open access · CC-BY
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
Frontiers in Medicine 2018
Open access · CC-BY
Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
Frontiers in Immunology 2018
Open access · CC-BY
Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
Diabetes 2008
Open access · CC-BY